Endpoints News
CMS unveils negotiated prices for Ozempic, Wegovy and other drugs Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
Wednesday
3 December, 2025
presented by Lilly
Elim­i­nat­ing the bar­ri­ers to mod­ern clin­i­cal tri­als: Let’s fin­ish the job
top stories
1. Top drug regulator Rick Pazdur set to leave FDA, prompting industry concern
2. FDA and Prasad's Covid vaccine death claims lack key details
3. FDA says it won't release details of claimed Covid vaccine deaths in 'near term'
4. Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks
5. New ACIP chair compares Covid requirements to Holocaust, says shots caused cancer, miscarriages
6. UK to spend more on medicines for US tariff exemption
7. FDA to remove some monkey testing from monoclonal antibody development
8. House passes bill to reauthorize rare pediatric PRV program; Senate next
Zachary Brennan
.

It's been just weeks since FDA Commissioner Marty Makary lobbied Rick Pazdur at his home to take the role of FDA's top drug official. And yet, Pazdur on Monday said he'll retire, with sources pointing to disagreements with Makary and with CBER Director Vinay Prasad's email to staff on newly unearthed Covid-19 vaccine deaths in children and other major changes he's floating (see below), among other issues. Who will replace Pazdur as the fifth CDER director of this year? It remains unknown. Staffers said the agency hasn't even announced that he'll retire internally, which didn't come as a surprise as they never received an email on George Tidmarsh's sudden departure as the last CDER chief. Pazdur was installed by Makary to establish some sense of continuity for experienced CDER staff that haven't left yet, but some current and recently departed FDAers told us that they're concerned Pazdur's departure may spur an even wider exodus

.
Zachary Brennan
Senior Editor, Endpoints News
@ZacharyBrennan
Richard Pazdur
1
by Max Bayer, Zachary Brennan

Rick Paz­dur, the head of the FDA's drug of­fice, is ex­pect­ed to leave the agency less than a month af­ter step­ping in­to the role.

His ex­it comes af­ter he was per­son­al­ly lob­bied by Com­mis­sion­er Mar­ty Makary to take the job, and was giv­en as­sur­ances that he would be shield­ed from some of the chaot­ic dy­nam­ics that have af­fect­ed oth­er parts of the FDA, ac­cord­ing to pre­vi­ous re­port­ing by End­points News.

But he quick­ly clashed with Makary over a new Na­tion­al Pri­or­i­ty Vouch­er pi­lot pro­gram, say­ing that it may be il­le­gal. And he pushed back on at­tempts by Makary’s re­quests for la­bel changes and to pull cer­tain un­spec­i­fied drugs, End­points has re­port­ed.

Click here to continue reading
2
by Zachary Brennan

A top FDA of­fi­cial's claim that Covid vac­cines caused at least 10 deaths in chil­dren has yet to be backed up by the da­ta that typ­i­cal­ly ac­com­pa­ny ma­jor safe­ty an­nounce­ments, in­clud­ing de­tails of the al­leged deaths, which vac­cines were used, and case re­ports that could help clin­i­cians and re­searchers make their own as­sess­ments.

The claim, made in a lengthy email to staff on Fri­day by CBER Di­rec­tor Vinay Prasad, de­scribes the al­leged deaths as "a pro­found rev­e­la­tion" about the safe­ty of the shots. It al­so calls for sig­nif­i­cant changes to the reg­u­la­tion of child­hood vac­cine ap­provals, and comes just days be­fore HHS Sec­re­tary Robert F. Kennedy Jr.'s hand­picked group of CDC ad­vi­sors will dis­cuss the child­hood vac­cine sched­ule — and po­ten­tial­ly rec­om­mend changes to the prac­tice of giv­ing the he­pati­tis B vac­cine soon af­ter birth.

Click here to continue reading
3
by Zachary Brennan

De­tails from an in­ves­ti­ga­tion by CBER Di­rec­tor Vinay Prasad in­to 10 al­leged child deaths re­lat­ed to Covid-19 vac­cines won't be com­ing soon, an FDA spokesper­son told End­points News on Wednes­day.

FDA spokesper­son Caleb Michaud said the agency was not re­leas­ing any more de­tails in the "near term," since "there are ad­di­tion­al ad­verse event cas­es be­ing in­ves­ti­gat­ed." Michaud did not say what those ad­verse events were, or if they were deaths.

Late last week, Prasad sent an in­ter­nal email to CBER staff claim­ing that 10 vac­cine-re­lat­ed deaths were un­cov­ered by “an ini­tial analy­sis of 96 deaths be­tween 2021 and 2024.” The email was re­port­ed by End­points News and oth­er me­dia out­lets, but the agency has not made any of­fi­cial pub­lic state­ments, un­like in past in­stances when it has in­ves­ti­gat­ed sig­nif­i­cant safe­ty risks where it felt a need to in­form the pub­lic and med­ical pro­fes­sion­als.

Click here to continue reading
4
by Nicole DeFeudis

The gov­ern­ment on Tues­day an­nounced fi­nal prices for the sec­ond round of drugs ne­go­ti­at­ed by Medicare un­der the In­fla­tion Re­duc­tion Act, in­clud­ing for No­vo Nordisk’s block­buster semaglu­tide prod­ucts Ozem­pic and We­govy.

The ne­go­ti­at­ed prices are up to 85% low­er than the list prices for the drugs.

The an­nounce­ment gives the first sub­stan­tive look at how IRA ne­go­ti­a­tions tran­spired un­der the Trump ad­min­is­tra­tion, which has pledged to use mul­ti­ple ap­proach­es to low­er drug prices. CMS said it ac­cept­ed drug­mak­ers’ re­vised coun­terof­fers for sev­en of the drugs.

The gov­ern­ment said that when the prices take ef­fect in 2027, pa­tients en­rolled in Medicare pre­scrip­tion drug cov­er­age will save an es­ti­mat­ed $685 mil­lion in out-of-pock­et costs. If the ne­go­ti­at­ed prices had tak­en ef­fect in 2024, CMS es­ti­mates that they would have saved Medicare $12 bil­lion in net pre­scrip­tion drug costs. That fig­ure doesn’t ac­count for  spend­ing on the Cov­er­age Gap Dis­count Pro­gram, which end­ed in 2025. When tak­ing that pro­gram in­to ac­count, es­ti­mat­ed sav­ings would have been about $8.5 bil­lion.

Click here to continue reading
ACIP chair Kirk Milhoan (Brynn Anderson/AP Images)
5
by Max Bayer

The new leader of the CD­C's flag­ship vac­cine ad­vi­so­ry group re­cent­ly claimed that Covid-19 vac­cines were re­spon­si­ble for a rise in can­cer cas­es, and that the vast ma­jor­i­ty of women who get the vac­cine in their first trimester have mis­car­riages.

The com­ments by Kirk Mil­hoan, who serves as chair­man of the CD­C's Ad­vi­so­ry Com­mit­tee on Im­mu­niza­tion Prac­tices, were made at a Texas church and post­ed on YouTube in Oc­to­ber. Mil­hoan al­so com­pared pan­dem­ic-era vac­ci­na­tion record cards to Jews who were forced to wear spe­cif­ic arm­bands dur­ing the Holo­caust.

"And what they said is, if you did­n't get the vac­cine, then you were dirty, right? So that brings up all the is­sues of what hap­pened when the Jews had to wear the yel­low Star of David, right? They were the dirty ones," he said in the video.

Click here to continue reading
6